Postoperative Outcomes after Off-Pump Coronary Artery Bypass Grafting in EuroSCORE Low- and High-Risk Women
Background. Many previous studies have reported that women who undergo coronary artery bypass grafting have higher perioperative morbidity and mortality rates than men. The use of off-pump coronary artery bypass grafting (OPCAB) has been suggested to decrease morbidity and mortality because the deleterious effects of cardiopulmonary bypass, particularly in high-risk patients, are avoided. The reduction in unwanted postoperative complications in women undergoing OPCAB surgery has not been extensively investigated. The aim of this retrospective study was to compare perioperative rates of morbidity and mortality and follow-up events after OPCAB in female patients assessed as high- or low-risk according to the European System for Cardiac Operative Risk Evaluation (EuroSCORE).
Methods. The study included 377 adult female patients who underwent elective primary isolated OPCAB. The study patients were divided into 2 groups based on the Additive EuroSCORE: low-risk patients (group I, n = 301, EuroSCORE <6) and high-risk patients (group II, n = 76, EuroSCORE ? 6).
Results. Patient ages were 60.1 ± 7.77 years in group I and 69.3 ± 5.51 years in group II (P <.001). Compared to group I patients, group II patients had significantly higher Additive EuroSCORE (P <.001), predicted mortality rate (Logistic EuroSCORE) (P <.001), and Canada angina classification (P <.001) and higher rates of preoperative myocardial infarction (P <.001), peripheral vascular disease (P <.001), carotid artery disease (P <.005), and hypertension (P <.05). Occurrence of postoperative arrhythmia and mortality were significantly higher (P <.05) in group II. The observed mortality rate in group I was 1%, which was 41% of the predicted mortality rate (Logistic EuroSCORE) of 2.42 ± 0.76. The observed mortality rate in group II was 5.3%, which was 79% of the predicted rate (6.74 ± 2.89), but the difference was not significant (P = .2). Intensive care unit length of stay (P <.01) and ventilation times (P <.05) were longer for group II than group I, and the incidence of conversion to cardiopulmonary bypass was 1.6% versus 5.3%, respectively, in groups I and II (P = .08).
Conclusion. These results indicate that OPCAB surgery is safe and seems to be an effective surgical technique for lowering rates of morbidity and mortality in high- and lowrisk female patients.
Aldea GS, Gaudiani JM, Shapira OM, et al. 1999. Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. Ann Thorac Surg 67:1097-103.nAllen KB, Matheny RG, Robinson RJ, Heimansohn DA, Shaar CJ. 1997. Minimally invasive versus conventional reoperative coronary artery bypass. Ann Thorac Surg 64:616-22.nArom KV, Flavin TF, Emery RW, Kshettry VR, Janey PA, Petersen RJ. 2000. Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg 69:704-10.nAscione R, Nason G, Al-Ruzzeh S, Ko C, Ciulli F, Angelini GD. 2001. Coronary revascularization with and without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency. Ann Thorac Surg 72:2020-5.nAscione R, Rees K, Santo K, et al. 2002. Coronary artery bypass grafting in patients over 70 years old: the influence of age and surgical technique on early and mid-term clinical outcomes. Eur J Cardiothorac Surg 22:124-8.nBenetti FJ, Naselli G, Wood M, Geffner L. 1991. Direct myocardial revascularization without extracorporeal circulation: experience in 700 patients. Chest 100:312-6.nBergsland J, Hasnain S, Lajos TZ, Salerno TA. 1998. Elimination of cardiopulmonary bypass: a prime goal in reoperative coronary artery bypass surgery. Eur J Cardiothorac Surg 14:59-63.nBittner H, Savitt M, McKeown PP, Lucke JC. 2001. Off-pump coronary artery bypass grafting: excellent results in a group of selected high-risk patients. J Cardiovasc Surg (Torino) 42:451-6.nBoyd WD, Desai ND, Del Rizzo DF, Novick RJ, McKenzie FN, Menkis AH. 1999. Off-pump surgery decreases postoperative complications and resource utilization in the elderly. Ann Thorac Surg 68:1490-3.nBrown PP, Mack MJ, Simon AW, et al. 2002. Outcomes experience with off-pump coronary artery bypass surgery in women. Ann Thorac Surg 74:2113-9.nCalafiore AM, Teodori G, Di Giammarco G, et al. 1999. Multiple arterial conduits without cardiopulmonary bypass: early angiographic results. Ann Thorac Surg 67:450-6.nChamberlain MH, Ascione R, Reeves BC, Angelini GD. 2002. Evaluation of effectiveness of off-pump coronary artery bypass grafting in high-risk patients: an observational study. Ann Thorac Surg 73:1866-73.nChristakis GT, Weisel RD, Buth KJ, et al. 1995. Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg 110:1344-56.nCollard E, Ducart A, Buche M, et al. 1997. Postoperative morbidity after coronary artery bypass graft surgery without cardiopulmonary bypass [abstract]. Br J Anaesth 78(Suppl 2):43.nEdwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. 1998. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 66:125-31.nKing RC, Reece TB, Hurst JL, et al. 1997. Minimally invasive coronary bypass grafting decreases hospital stay and cost. Ann Surg 225:805-11.nNashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13.nO'Connor GT, Morton JR, Diehl MJ, et al. 1993. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. Circulation 88:2104-10.nPetro KR, Dullum MK, Garcia JM, et al. 2000. Minimally invasive coronary revascularization in women: a safe approach for a high-risk group. Heart Surg Forum 3:41-6.nPuskas JD, Williams WH, Duke PG, et al. 2003. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:797-808.nRiha M, Danzmayr M, Nagele G, et al. 2002. Off-pump coronary artery bypass grafting in EuroSCORE high and low risk patients. Eur J Cardiothorac Surg 21:193-8.nRoques F, Nashef SA, Michel P, et al. 1999. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816-823.nRoques F, Nashef SA, Michel P, Pinna Pintor P, David M, Baudet E. 2000. The EuroSCORE Study Group: does EuroSCORE work in individual European countries? Eur J Cardiothorac Surg 18:27-30.nSergeant P, de Worm E, Meyns B, Wouters P. 2001. The challenge of departmental quality control in the reengineering towards off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 20:538-43.nShroyer AL, Coombs LP, Peterson ED, et al. 2003. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75:1856-64.nStamou SC, Pfister AJ, Dangas G, et al. 2000. Beating heart versus conventional single vessel reoperative coronary artery bypass surgery. Ann Thorac Surg 69:1383-7.nTan ES, van der Meer J, Jan de Kam P, et al. 1999. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. J Am Coll Cardiol 34:1760-8.nTasdemir O, Vural KM, Karagoz H, Beyazit K. 1998. Coronary artery bypass grafting on the beating heart without the use of extracorporeal circulation: review of 2052 cases. J Thorac Cardiovasc Surg 116:68-73.nWoods SE, Noble G, Smith JM, Hasselfeld K. 2003. The influence of gender in patients undergoing coronary artery bypass graft surgery: an eight-year prospective hospitalized cohort study. J Am Coll Surg 196:428-34.nYokoyama T, Baumgartner FJ, Gheissari A, Capouya ER, Panagiotides GP, Declusin RJ. 2000. Off-pump versus on-pump coronary bypass in highrisk subgroups. Ann Thorac Surg 70:1546-50.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).